Zoledronate prevents fractures in older women when administered every 12 to 18 months, but its effects on bone density and bone turnover persist beyond 5 years. Whether infrequent zoledronate ...
Fri, January 10, 2025 at 1:17 AM UTC ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback